This paper demonstrates rapid technology transfer of an external CHO cell line (Sartorius 4Cell SmartCHO) into FUJIFILM Biotechnologies’ standardized mAb...

Peter Skals, Head of Global Sustainability, FUJIFILM Biotechnologies, explores how we are integrating our climate and ESG strategy while simultaneously expanding our CDMO network and…

This webinar will offer a glimpse into the flexible and smart designs included in the capacity expansion project at our Thousand Oaks, CA facility.

Rasmus Pedersen outlines strategies to expand large-molecule production capacity to meet growing global medicine demand, noting the current gap that leaves 2 billion people without…

Charlie Heise delves into the importance of selecting the most suitable manufacturing strategy and how kojoX™, combined with our ApolloX™ technology, can streamline the process…

Read more below about how Maja Pederson, Chief Quality Officer at FUJIFILM Biotechnologies, has used her expertise in bioprocess development, compliance, manufacturing, and regulatory compliance…

By leveraging our capabilities and expertise, you can confidently navigate the biopharmaceutical development landscape to bring antibody-based treatments to patients worldwide.

In case you missed it, Sara Miller, Associate Director, Product Offering Lead - Cell Therapy at FUJIFILM Biotechnologies, presented a Cell Therapy New Product Introduction…

Hear from the first PhD graduates of the Centre of Excellence in Bioprocessing - a dynamic academic-industry partnership at the intersection of bioprocess innovation and…

Learn how the challenges we encountered as a cell therapy innovator company shaped our vision for the evolving relationship with CDMOs.